The polyglycolic acid synthetic absorbable surgical suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological procedures.
The surgical absorbable P.G.A (polyglycolic acid) sutures features 40mm 1 - 3/8 cycle reverse cutting needle and synthetic, braided and copolymer coated fiber of violet color and length of 75cm.
Polyglycolic acid synthetic absorbable surgical suture elicits a minimal acute infl ammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fi brous connective tissue.
Progressive loss of tensile strength and eventual absorption of polyglycolic acid synthetic absorbable sutures occurs hydrolysis, where the polymer degrades to glycolic acid which is subsequently absorbed and metabolized by the body.
Absorption begins as a loss of tensile strength without appreciable loss of mass. polyglycolic acid synthetic absorbable suture PGA retains approximately 75% of the average E.P. tensile strength requirement at the end of the 2nd post implantation week, and more than 35% at the end of the 3rd week. The absorption of the suture is essentially complete between 50 and 90 days.
Suture length: 75cm